Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.

Hernández-Molina G, Espericueta-Arriola G, Cabral AR.

Clin Exp Rheumatol. 2013 May-Jun;31(3):382-8. Epub 2013 Jan 10.

PMID:
23305633
[PubMed - indexed for MEDLINE]
3.

Antiphospholipid syndrome: critical analysis of the diagnostic path.

Pengo V, Banzato A, Bison E, Denas G, Padayattil Jose S, Ruffatti A.

Lupus. 2010 Apr;19(4):428-31. doi: 10.1177/0961203309360543.

PMID:
20353982
[PubMed - indexed for MEDLINE]
4.

Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome.

Pasoto SG, Chakkour HP, Natalino RR, Viana VS, Bueno C, Lianza AC, de Andrade JL, Neto ML, Fuller R, Bonfa E.

Clin Rheumatol. 2012 Sep;31(9):1331-8. doi: 10.1007/s10067-012-2019-z. Epub 2012 Jun 13.

PMID:
22692396
[PubMed - indexed for MEDLINE]
5.

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.

Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E.

Lupus. 2007;16(1):39-45.

PMID:
17283584
[PubMed - indexed for MEDLINE]
6.

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.

Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S.

J Thromb Haemost. 2010 Feb;8(2):237-42. doi: 10.1111/j.1538-7836.2009.03674.x. Epub 2009 Oct 30.

PMID:
19874470
[PubMed - indexed for MEDLINE]
7.
8.

Antibody profiles for the diagnosis of antiphospholipid syndrome.

Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S.

Thromb Haemost. 2005 Jun;93(6):1147-52.

PMID:
15968401
[PubMed - indexed for MEDLINE]
9.

The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.

Neville C, Rauch J, Kassis J, Solymoss S, Joseph L, Belisle P, Subang R, Chang ER, Fortin PR.

Rheumatology (Oxford). 2006 Sep;45(9):1116-20. Epub 2006 Mar 1.

PMID:
16510527
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.

Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V.

Thromb Haemost. 2006 Sep;96(3):337-41.

PMID:
16953276
[PubMed - indexed for MEDLINE]
11.
12.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209
[PubMed - indexed for MEDLINE]
13.

Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.

Galli M.

Semin Thromb Hemost. 2008 Jun;34(4):329-34. doi: 10.1055/s-0028-1085474. Epub 2008 Sep 23. Review.

PMID:
18814065
[PubMed - indexed for MEDLINE]
14.

Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets.

Ferrer-Oliveras R, Llurba E, Cabero-Roura L, Alijotas-Reig J.

Lupus. 2012 Mar;21(3):257-63. doi: 10.1177/0961203311425520. Epub 2011 Nov 7.

PMID:
22065091
[PubMed - indexed for MEDLINE]
15.

APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.

Int J Clin Exp Pathol. 2012;5(3):210-5. Epub 2012 Mar 25.

PMID:
22558475
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.

Djokovic A, Stojanovich L, Kontic M, Stanisavljevic N, Radovanovic S, Marisavljevic D.

Isr Med Assoc J. 2014 Mar;16(3):162-7.

PMID:
24761704
[PubMed - indexed for MEDLINE]
Free Article
17.

Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.

Viveros ME, Cabiedes J, Reyes E, Cabral AR.

Rev Invest Clin. 2005 Jul-Aug;57(4):563-71.

PMID:
16315641
[PubMed - indexed for MEDLINE]
18.

Antiphospholipid antibody profile: implications for the evaluation and management of patients.

Tincani A, Andreoli L, Casu C, Cattaneo R, Meroni P.

Lupus. 2010 Apr;19(4):432-5. doi: 10.1177/0961203310361491.

PMID:
20353983
[PubMed - indexed for MEDLINE]
19.

Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.

Stojanovich L, Kontic M, Djokovic A, Ilijevski N, Stanisavljevic N, Marisavljevic D.

Scand J Rheumatol. 2012 May;41(3):223-6. doi: 10.3109/03009742.2011.641580. Epub 2012 Feb 13.

PMID:
22324785
[PubMed - indexed for MEDLINE]
20.

Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study.

Turiel M, Sarzi-Puttini P, Peretti R, Rossi E, Atzeni F, Parsons W, Doria A.

Stroke. 2005 Jul;36(7):1490-4. Epub 2005 Jun 9.

PMID:
15947270
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk